Shanxi Eye Hospital

Running trials

• Recruiting

  Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

  NCT07776522· Phase 2· Source

• Recruiting

  Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

  NCT07317934· Phase 3· Source

• Not yet recruiting

  A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

  NCT07365371· Phase 4· Source

• Recruiting

  A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  NCT06962839· Phase 2· Source

• Active, not recruiting

  A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

  NCT06666855· Phase 3· Source

• Active, not recruiting

  A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China

  NCT06548568· Source

• Active, not recruiting

  A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

  NCT05562947· Phase 3· Source

• Active, not recruiting

  Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)

  NCT06196840· Phase 2· Source

• Active, not recruiting

  TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

  NCT05461339· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration3 recruiting
• Diabetic eye disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects With DME

  NCT06708260· Phase 2· Source

• Completed

  A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema

  NCT06422507· Phase 3· Source

• Completed

  Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT05003245· Phase 3· Source

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Source

Trial sites

• Shanxi eye hospital2 trials
• Shanxi Eye Hospital10 trials
• Shanxi Eye Hospital /ID# 2705641 trial